# Opmed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/opmed

- Industry: Healthcare IT
- Headquarters: Boston, US
- Website: www.opmed.ai
- Total disclosed funding: $15M
- Latest round: Series A (May 6, 2024)
- Investors on record: 4

## About

Based in Massachusetts, US, and founded in 2022 by CEO Dr. Mor Brokman Meltzer, CTO Avi Paz, and Prof. Baruch Barzel, Opmed Inc., a.k.a. Opmed.ai, operates as a health technology company that offers artificial intelligence-based software-as-a-service to automate the scheduling of operating room activities. In May 2024, Opmed Inc. raised USD 15 million in a Series A funding co-led by NFX and Grove Ventures, with participation from Secret Chord Ventures and Unbox Ventures.

The company provides an AI optimization platform that specializes in optimizing healthcare operations, starting with operating rooms. Opmed.ai’s adaptive OR optimization engine elevates efficiency through daily scheduling, mid-term, and long-term strategic planning. With predictive analytics, the platform manages day-to-day operations, allocates surgical blocks, and aligns staffing with case volumes. The platform integrates seamlessly with existing systems, ensuring collaborative communication and real-time updates. Opmed.ai's AI-driven approach empowers healthcare facilities to reduce waiting times, enhance staff morale, and improve operational efficiency.

The company plans to use its proceeds from May 2024 funding to scale up its platform rapidly to meet strong demand from US hospitals.

## Funding rounds

- Series A, May 6, 2024, $15M — Grove, NFX, Secret Chord Ventures, Unbox Ventures

## Investors

- Grove (https://capitalatlas.ai/funds/grove) — Series A
- NFX (https://capitalatlas.ai/funds/nfx) — Series A
- Secret Chord Ventures (https://capitalatlas.ai/funds/secret-chord-ventures) — Series A
- Unbox Ventures — Series A